Intervention not reported
NODAT (ESW alemtuzumab only) · kidney transplant recipients
The intervention showed no clear difference in NODAT (ESW alemtuzumab only) (low certainty).
1 finding from 1 review
- Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients 2017 · Cochrane Headline outcomes onlyRR 0.41 [0.12, 1.4]2 studies · 69 participantsLow